Cardiotext Logo
Hello, Guest.
Cardiotext Rewards Program Free Shipping on domestic orders of $99.00 or more McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Product Detail

Fundamental Approaches to the Management of Cardiac Arrhythmias

Ruey J. Sung


Shipping Calculator

Request a Quote for 10+ Copies

Tell A Friend

More Info...
Fundamental Approaches to the Management of Cardiac Arrhythmias Retail Price: $399.00
Cardiotext Price: $391.02

Availability: Processing time varies. Price is tentative.

Alert me when this product is available
Availability Questions?


Product Information:
ISBN-13: 9780792365594
ISBN-10: 0792365593
Publisher: SPRINGER
Format: Hardcover, 804 pages
Pub Date: 01/2000
Edition Number: 1




Synopsis

Stanford Univ., CA. Clinically oriented textbook and reference of cardiac electrophysiology. For electrophysiologists, cardiologists, residents, nurses, and technologists. Presents fundamental principles and concepts, diagnosis and management, and the latest pharmacotherapy options.



Similar Items



Customer Reviews
Be the first to review this product



Browse Titles In Related Subjects

Additional Description

CONTENTS

Preface vii
Acknowledgments xiii

1 Functional Anatomy and Mechanisms of Cardiac
Arrhythmias
1.1 Functional Anatomy of the Conduction System 1
1.2 Vascular Supply to the Conduction System 6
1.3 Autonomic Innervation & Nervous Control 6
1.4 Mechanisms of Cardiac Arrhythmias 7
1.5 Arrhythmogenic Anatomy 11

2 Basic Principles of Clinical Cardiac Electrophysiology
2.1 Electrophysiology Procedures: Preparation and
Performance 21
2.2 The Basic Diagnostic Electrophysiological
Evaluation 41

3 Principles of Pharmacotherapy and Antiarrhythmic Drugs
3.1 Principles of Pharmacokinetics and
Pharmacodynamics 91
3.2 Molecular and Biophysical Targets for
Antiarrhythmic Drugs 102
3.3 Classification of Antiarrhythmic Drugs 113
3.4 Modulated Receptor Theory of Antiarrhythmic
Drug Action 114
3.5 Proarrhythmic Effects of Antiarrhythmic Drugs
125

4 Principles of Electrode Catheter Ablation
4.1 Indications for Ablation of Cardiac Arrhythmias
131
4.2 ABCs of Electrode Catheter Ablation 131
4.3 Arrhythmia Induction 135
4.4 Arrhythmia Localization 136
4.5 Delivery of Ablation Energy 153
4.6 Confirmation of Successful Ablation 165
4.7 Future Directions 167

5 Principles of Pacemaker Therapy
5.1 Historical Perspectives 173
5.2 Indications for Pacemaker Therapy 174
5.3 Basic Concepts & Biophysical Aspects of Pacing
175
5.4 Pacemaker Operation, Programmability &
Timing Cycles 211
5.5 Pacemaker Implantation 245
5.6 Pacemaker Follow-up 248
5.7 Pacemaker Troubleshooting 265
6 Implantable Card ioverter-Defibrillator Therapy
6.1 Historical Perspectives 288
6.2 Indications for ICD Therapy 290
6.3 Basic Concepts of Defibrillation 291
6.4 Components of ICD Systems 303
6.5 CD Operation and Programmability 317
6.6 Bradyarrhythmia Therapy 364
6.7 ICD System Implantation 364
6.8 Clinical Follow-up and Troubleshooting of ICD
Systems 386

7 Diagnosis and Acute Management of Patients with
Symptomatic Bradyarrhythmias
7.1 Localization of Conduction Disturbance 418
7.2 Urgent Management of Conduction Failure 421

8 Diagnosis and Acute Management of Patients with
Symptomatic Tachyarrhythmias
8.1 Supraventricular Tachyarrhythmias 429
8.2 Ventricular Tachyarrhythmias 439

9 Disturbances of Sinoatrial Node Function
9.1 Sinoatrial Node Dysfunction and Exit Block 454
9.2 Assessment of Sinoatrial Node Function 458
9.3 Treatment Strategies for Patients with SA Node
Dysfunction 464

10 Disturbances of Atrioventricular Conduction
10.1 Normal AV Conduction 469
10.2 Abnormalities of AV Conduction 472
10.3 Management of AV Conduction Disturbances
484

11 Atrioventricular Nodal Reentrant Tachycardia
11.1 Cellular Electrophysiology of the AV Node
488
11.2 Neuropharmacologic Responses of the AV
Node 492
11.3 Clinical Electrophysiology 493
11.4 Catheter Ablation of AV Nodal Reentrant
Tachycardia 509

12 Ventricular Preexcitation Syndromes: The
Wolff-Parkinson White Syndrome and Variants
12.1 The Physiology of Ventricular Preexcitation
539
12.2 Electrophysiology Study 541
12.3 Concealed Wolff-Parkinson-White Syndrome
556
12.4 Accessory Connections with Decremerital
Conduction Properties 561
12.5 Pharmacological Effects on Accessory
Connections 572
12.6 Differential Diagnosis 575
12.7 Radiofrequency Catheter Ablation 586
12.8 Surgery 602

13 Atrial Tachycardias and Atrial Flutter
13.1 Classification of Atrial Tachycardias 609
13.2 Focal Atrial Tachycardia 609
13.3 Inappropriate Sinus Tachycardia 624
13.4 Macroreentrant Atrial Tachycardia 626
13.5 Pharmacological Therapy for Atrial
Tachyarrhythmias 634
13.6 Catheter Ablation of Atrial Tachyarrhythmias
637
13.7 Pacemaker Therapy for Atrial Tachyarrhythmias
649

14 Atrial Fibrillation
14.1 Pathological Findings 657
14.2 Electrophysiologic Mechanisms 659
14.3 Classification of Atrial Fibrillation 661
14.4 Pharmacotherapy for Atrial Fibrillation 662
14.5 Non-pharmacological Therapies 669

15 The Spectrum of Monomorphic Ventricular Tachycardia
15.1 Electrophysiologic Mechanisms 687
15.2 Electrophysiology Study 691
15.3 Pharmacologic Testing 692
15.4 Verapamil-nonresponsive Ventricular
Tachycardia 692
15.5 Verapamil-Responsive Ventricular Tachycardia
696
15.6 Exercise-induced Ventricular Tachyarrhythmias
703
15.7 Idiopathic Ventricular Tachycardia 709
15.8 Management of Chronic Recurrent Ventricular
Tachycardia 712
15.9 Radiofrequency Catheter Ablation 713
15.10 Chemical Ablation of Ventricular Tachycardia
719
15.11 Surgical Intervention 720

16 Polymorphic Ventricular Tachycardia and Long QT
Syndromes
16.1 Clinical Significance 732
16.2 Mechanisms of QRS Complex Polymorphism
733
16.3 Classification of Long QT Syndromes 735
16.4 Cellular Mechanisms of Long QT Syndromes
and Torsade de Pointes 738
16.5 The Acquired Long QT Syndromes and Torsade
de Pointes 742
16.6 The Hereditary Long QT Syndromes 745
16.7 Treatment of Polymorphic Ventricular
Tachycardia & Long QT Syndromes 746

17 Ventricular Fibrillation and Sudden Cardiac Death
17.1 Definition and Epidemiology 764
17.2 Type of Arrhythmias Associated with Sudden
Cardiac Death 764
17.3 Clinical Profile of Survivors of Sudden Cardiac
Death 766
17.4 Role of Autonomic Nervous System in Sudden
Arrhythmic Death 766 766
17.5 Risk Stratification & Predictors of Sudden
Arrhythmic Death 768
17.6 Evaluation of Patients Surviving a Cardiac
Arrest 770
17.7 Treatment of Survivors of Sudden Arrhythmic
Death 773
17.8 Primary Prevention of Sudden Cardiac Death
780

Index 793